JAMP NEBIVOLOL
Identification of Jamp Nebivolol
No description |
Google image searchProduct monograph
Active ingredient
nebivolol (nebivolol hydrochloride), 5 MG
DIN: 02543508
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 16-SEP-2024
ATC:
- C07 — BETA BLOCKING AGENTS (ATC, ATC/DDD, )
- C07A — BETA BLOCKING AGENTS (ATC, ATC/DDD)
- C07AB — Beta blocking agents, selective (ATC, ATC/DDD)
- C07AB12 — NEBIVOLOL (ATC/DDD)
Reference brand drug: Bystolic